Skip to main content
SpringerLink
Log in

The effect of orlistat on body weight in obese Czech adults

  • Research Article
  • Published:
Central European Journal of Medicine

Abstract

Objectives

The effectiveness of pharmacologic support with orlistat is shown on a group of the obese patients.

Methods

In ambulatory patients, basic anthropometric parameters as body weight, BMI, waist circumference and the total amount of adipose tissue were compared before substitution with 120 mg orlistat three times a day and after a four-month therapy. This group included 52 patients who were administered the same dose of orlistat for the whole period of time. The control group consisted of 49 patients. These patients were not administered orlistat.

Results

After a four-month therapy with orlistat there was a mean reduction in weight by 6.7 ± 2.6 kg in the monitored group of patients. Their BMI was reduced by 2.0 ± 0.9 kg/m2 and the waist circumference by 3.7 ± 3.3 cm. The decrease in the percentage of the total body lipid was 2.5 %. There was a statistically significant reduction in all of the monitored parameters. In the control group, there was no statistically significant decrease in the majority of the monitored parameters.

Conclusion

We can state that in our patients we have proven a positive effect of orlistat substitution on their weight reduction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Reaven P., Metabolic syndrome, J. Insur. Med., 2004, 36, 132–142

    PubMed  Google Scholar 

  2. Ginter E, Simko V., Adult obesity at the beginning od the 21st century: epidemiology, pathophysiology and health risk, Bratisl. Lek. Listy, 2008, 109, 224–230

    PubMed  CAS  Google Scholar 

  3. Waden T.A, Berkowitz R.I, Womble L.G., Randomized trial of lifestyle modification and pharmacotherapy for obesity, N. Engl. J. Med., 2005, 353, 2111–2116

    Article  Google Scholar 

  4. Svendsen M, Tonstad S., Orlistat after initial dietary/behavioural treatment: changes in body weight and dietary maintenance in subjects with sleep related breathing disorders, Nutr. J., 2011, 8, 10–21

    Google Scholar 

  5. Torp-Pedersen C, Caterson I, Coutinho W., Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial, Eur. Heart. J., 2007, 28(23), 2915–2923

    Article  PubMed  Google Scholar 

  6. James W.P, Caterson I.D, Coutinho W., Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects, N. Engl. J. Med., 2010, 363(10), 905–917

    Article  PubMed  CAS  Google Scholar 

  7. Hainer V., Comparative efficiency and safety of pharmacological approaches to the management of obesity. Diabetes Care, 2011, 34, 349–354

    Article  Google Scholar 

  8. Bray G.A., Medical therapy for obesity, Mt. Sinai J. Med., 2010, 77(5), 407–417

    Article  PubMed  Google Scholar 

  9. Li Z, Maglione M, Tu W., Pharmacologic treatment of obesity, Ann. Intern. Med., 2005, 142, 532–538

    Article  PubMed  CAS  Google Scholar 

  10. Hainer V., Orlistat a perspektivy farmakoterapie obezity, JAMA, 1999, 7, 371–373

    Google Scholar 

  11. Li M.F, Cheung B.M., Rise and fall of anti-obesity drugs, World J. Diabetes, 2011, 15(2), 19–23

    Article  Google Scholar 

  12. Jain S.S, Ramajane S.J, Akat P.B., Evaluation of efficacy and safety of orlistat in obese patients, Indian J. Endocrinol. Metab., 2011, 15(2), 99–104

    Article  PubMed  CAS  Google Scholar 

  13. Derosa G, Maffioli P, Salvadeo S.A., Comparison of orlistat treatment and placebo in obese type 2 diabetic patients, Expert Opin. Pharmacother., 2010, 11(12), 1971–1982

    Article  PubMed  CAS  Google Scholar 

  14. Minarčíková I., Farmakoekonomické aspekty ve farmakoterapii obezity, Česká a Slov. Farm., 2003, 52, 258–261

    Google Scholar 

  15. Hainer V., Comment to the article: Assessment of morbid obesity treatment cost efficiency in the Czech Republic, Diab. Metab. Endokr., 2012, 15(3), 199–200

    Google Scholar 

  16. Russell-Jones D., Gough S. Recent advances in incretin-based therapies, Clin. Endocrinol. 2012, 77(4), 489–499

    Article  CAS  Google Scholar 

  17. Hayes M.R., De Jonghe B.C., Kanoski S.E., Role of the glucagon-like-peptide-1 receptor in the control of energy balance, Physiology and Behavior, 2010, 100(5), 503–510

    Article  PubMed  CAS  Google Scholar 

  18. Allison D.B., Gadde K.M., Garvey W.T., Controlledrelease phentermine/topiramate in severely obese adults: a randomized controlled trial, Obesity, 2012, 20(2), 330–42

    Article  PubMed  CAS  Google Scholar 

  19. Gadde K.M., Day W.W., Low-dose, controlledrelease phentermin/topiramate for reduction of weight, Obesity reviews from 11th International Congress on Obesity, 11–15 July 2010 Stockholm, 2010, 11(1), 42–43

    Google Scholar 

  20. Ornellas T., Chavez B., A New Approach to Weight Loss in Obese Adults, Pharmacy and Therapeutics, 2011, 36(5), 255–256, 261–262

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Military Hygiene, Faculty of Military Health Sciences, University of Defence, Trebesska, Czech Republic

    Vladimír Pavlík & Jana Fajfrová

  2. Language Training Centre, Faculty of Military Health Sciences, University of Defence, Trebesska, Czech Republic

    Eva Drahokoupilová

Authors
  1. Vladimír Pavlík
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jana Fajfrová
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eva Drahokoupilová
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vladimír Pavlík.

About this article

Cite this article

Pavlík, V., Fajfrová, J. & Drahokoupilová, E. The effect of orlistat on body weight in obese Czech adults. cent.eur.j.med 8, 553–557 (2013). https://doi.org/10.2478/s11536-013-0194-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2478/s11536-013-0194-1

Keywords

Search

Navigation